These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5868390)

  • 1. Observations on the use of BHK 21 Clone 13 cells for foot-and-mouth disease vaccine production.
    Capstick PB; Garland AJ
    Bull Off Int Epizoot; 1965 May; 64():215-23. PubMed ID: 5868390
    [No Abstract]   [Full Text] [Related]  

  • 2. Some investigations and control procedures of foot-and-mouth disease vaccines produced from virus cultivated on BHK 21 Clone 13 cells.
    Kane GJ; Pay TW; Bracewell CD
    Bull Off Int Epizoot; 1965 May; 64():225-30. PubMed ID: 5895605
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of cell cultures in vaccine production: diploid and stable cell cultures.
    Matchett A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cultivation of foot-and-mouth disease virus type O in tissue cultures and utilization of its mutability for the production of new vaccine strains].
    Mitev G; Tekerlekov P
    Arch Exp Veterinarmed; 1966 Mar; 20(1):91-7. PubMed ID: 4293437
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the production of monovalent foot-and-mouth disease vaccine concentrate from tissue culture virus type O].
    Mitev G; Wassilewa L; Tekerlekov P
    Arch Exp Veterinarmed; 1966 Mar; 20(1):85-90. PubMed ID: 4293436
    [No Abstract]   [Full Text] [Related]  

  • 6. [An anti-foot-and-mouth disease vaccine from virus grown in a suspension of calf kidney cells].
    Likhachev NV; Zviagin IV; Makhniuk RA; Federova TL; Kazantseva NV; Molochnikov VA; San'kov SD; Zueva NIa
    Veterinariia; 1967 Jan; 44(1):24-5. PubMed ID: 5628675
    [No Abstract]   [Full Text] [Related]  

  • 7. Large-scale cultivation of animal cells in roller bottles for production of decigram amounts of pure foot-and-mouth disease virus.
    Bachrach HL
    Natl Cancer Inst Monogr; 1968 Dec; 29():73-9. PubMed ID: 4305442
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of temperature during passage on the properties of attenuated foot and mouth disease virus].
    Urvantsev NM; Siusiukin AA; Sergeev VA; Prokhorov VV
    Veterinariia; 1971 Jan; 1():37-9. PubMed ID: 4325013
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mulspilication of the vaccinal strain of foot-and mouth disease virus in the culture of various cells].
    Osidze NG
    Veterinariia; 1966 May; 43(5):17-8. PubMed ID: 4303712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the foot-and-mouth disease virus cultured on the BHK-21 cell line].
    Mitev G; Tekerlekov P
    Vet Med Nauki; 1973; 10(4):3-8. PubMed ID: 4370848
    [No Abstract]   [Full Text] [Related]  

  • 11. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Report on the characteristics of foot-and-mouth disease virus capable of being used as live vaccines].
    Asso J; Paraf A; Aynaud JM; Lucas A; Dhennin L; Gayot G
    Bull Off Int Epizoot; 1966; 65(11):1929-36. PubMed ID: 4296532
    [No Abstract]   [Full Text] [Related]  

  • 13. Suggested methods for the management and testing of a passaged diploid cell culture used for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):342-4. PubMed ID: 5316784
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety testing of rubella virus vaccine (Cendehill strain). Preparation in primary rabbit kidney cells.
    Huygelen C; Sigel MM; Zygraich N; Peetermans JH; Colinet G; Leyten R; Raupp WG; Pinto CA; Garg SG; Boyle JJ; Haff RF
    Am J Dis Child; 1969 Aug; 118(2):362-6. PubMed ID: 4978514
    [No Abstract]   [Full Text] [Related]  

  • 15. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle.
    Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A
    Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strains of foot-and-mouth viruses which can be used for live vaccines].
    Onoufriev V
    Bull Off Int Epizoot; 1966; 65(11):1967-73. PubMed ID: 5994042
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foot and mouth disease virus production on microcarrier-grown cells.
    Meignier B; Mougeot H; Favre H
    Dev Biol Stand; 1980; 46():249-56. PubMed ID: 6245001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Developments in foot-and-mouth disease (FMD) vaccine production (author's transl)].
    Barteling SJ
    Tijdschr Diergeneeskd; 1980 Sep; 105(17):695-8. PubMed ID: 6252656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.
    Guo H; Liu Z; Sun S; Bao H; Chen Y; Liu X; Xie Q
    Vaccine; 2005 May; 23(25):3236-42. PubMed ID: 15837227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.